FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria

被引：62
|
作者：
Sun, Hongcheng [1 ]
Teng, Mujian [2 ]
Liu, Jie [2 ]
Jin, Dong [3 ]
Wu, Junyi [1 ]
Yan, Dongwang [1 ]
Fan, Junwei [1 ]
Qin, Xuebin [4 ]
Tang, Huamei [5 ]
Peng, Zhihai [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 1, Dept Gen Surg, Shanghai 200080, Peoples R China
[2] Shangdong Univ, Affiliated Qianfoshan Hosp, Dept Hepatobiliary & Pancreat Surg, Jinan 250014, Shandong, Peoples R China
[3] Ningxia Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Yinchuan 750004, Ningxia Prov, Peoples R China
[4] Brigham & Womens Hosp, Dept Medicine, Boston, MA 02139 USA
[5] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 1, Dept Pathol, Shanghai 200080, Peoples R China
来源：
CANCER LETTERS | 2011年 / 306卷 / 02期
关键词：
Hepatocellular carcinoma; Orthotopic liver transplantation; FOXM1; Biomarker; TRANSCRIPTION FACTOR; EXPANSION; INVASION; IMPACT;
D O I：
10.1016/j.canlet.2011.03.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Molecular biomarker has been proposed to improve patient selection and post-transplant prognostication, but rare achievement has been made. In the present study, Forkhead box M1 (FOXM1) expression and its prognostic role have been investigated in hepatocellular carcinoma (HCC) treated by orthotopic liver transplantation (OLT). We found that the notably higher level of FOXM1 in tumors was associated with malignant pathological features of HCC and unfavorable outcome after OLT. The status of FOXM1 expression combined with the Milan criteria could make the prognostication more accurate and may be of particular interest for expanding the criteria in selecting transplant candidates. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：214 / 222
页数：9
相关论文
共 50 条
  • [1] Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma
    Fan, Weiqiang
    Ma, Huan
    Jin, Bin
    ONCOLOGY LETTERS, 2022, 23 (05)
  • [2] A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma
    Song, Bic-Na
    Chu, In-Sun
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 : e418 - e418
  • [3] A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma
    Bic-Na Song
    In-Sun Chu
    Experimental & Molecular Medicine, 2018, 50 : e418 - e418
  • [4] Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma
    Su, Wen-Lung
    Chuang, Shih-Chang
    Wang, Yu-Chu
    Chen, Lin-An
    Huang, Jian-Wei
    Chang, Wen-Tsan
    Wang, Shen-Nien
    Lee, King-Teh
    Lin, Chang-Shen
    Kuo, Kung-Kai
    CANCER BIOMARKERS, 2020, 28 (03) : 341 - 350
  • [5] OSTEOPONTIN EXPRESSION PREDICTS OVERALL SURVIVAL AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN PATIENTS BEYOND MILAN CRITERIA
    Sieghart, Wolfgang
    Schmid, Katharina
    Pinter, Matthias
    Bodingbauer, Martin
    Wrba, Fritz
    Rasoul-Rockenschaub, Susanne
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2010, 52 (04) : 1166A - 1167A
  • [6] Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria
    Sieghart, Wolfgang
    Wang, Xiaowei
    Schmid, Katharina
    Pinter, Matthias
    Koenig, Franz
    Bodingbauer, Martin
    Wrba, Fritz
    Rasoul-Rockenschaub, Susanne
    Peck-Radosavljevic, Markus
    JOURNAL OF HEPATOLOGY, 2011, 54 (01) : 89 - 97
  • [7] ORTHOTOPIC LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA PATIENTS EXCEEDING MILAN CRITERIA: AS GOOD AS IT GETS!
    Surjan, Rodrigo
    Sepulveda, Aillon
    Makdissi, Fabio
    Cosme, Andre
    Meirelles, Roberto
    Figueira, Estela
    Barros, Mauricio
    Andraus, Wellington
    Moura, Fabio
    Bronze, Rodrigo
    Rocha, Vinicius
    Machado, Marcel A.
    Machado, Marcel
    Bacchella, Teleslforo
    LIVER TRANSPLANTATION, 2008, 14 (07) : S131 - S131
  • [8] Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
    Chieh-Lin Teng
    Wen-Li Hwang
    Yi-Ju Chen
    Kuang-Hsi Chang
    Shao-Bin Cheng
    World Journal of Surgical Oncology, 10
  • [9] Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
    Teng, Chieh-Lin
    Hwang, Wen-Li
    Chen, Yi-Ju
    Chang, Kuang-Hsi
    Cheng, Shao-Bin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [10] Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
    Herrero, J. Ignacio
    Sangro, Bruno
    Pardo, Fernando
    Quiroga, Jorge
    Inarrairaegui, Mercedes
    Rotellar, Fernando
    Montiel, Custodia
    Alegre, Felix
    Prieto, Jesus
    LIVER TRANSPLANTATION, 2008, 14 (03) : 272 - 278
12345